Development and performance of prototype serologic and molecular tests for hepatitis delta infection

Development and performance of prototype serologic and molecular tests for hepatitis delta infection

Abstract Worldwide, an estimated 5% of hepatitis B virus (HBV) infected people are coinfected with hepatitis delta virus (HDV). HDV infection leads to increased mortality over HBV mono-infection, yet HDV diagnostics are not widely available. Prototype molecular (RNA) and serologic (IgG) assays were...

Full description

Bibliographic Details
Main Authors: Kelly E. Coller, Emily K. Butler, Ka-Cheung Luk, Mary A. Rodgers, Michael Cassidy, Jeffrey Gersch, Anne L. McNamara, Mary C. Kuhns, George J. Dawson, Lazare Kaptue, Birgit Bremer, Heiner Wedemeyer, Gavin A. Cloherty
Format: Article
Language:English
Published: Nature Publishing Group 2018-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-018-20455-5

Internet

https://doi.org/10.1038/s41598-018-20455-5

Similar Items